Customer Notification: Discontinuation of Abbott SARS-CoV-2 IgG assay

Printer-friendly versionPrinter-friendly version

Customer Notification: Abbott SARS-CoV-2 IgG assay will be discontinued

 

UCD NVRL is informing customers that the Abbott Anti-SARS-CoV-2 assay is being discontinued for Clinical Use. This is necessitated by the lack of kit controls.

 

UCD NVRL sincerely apologises for any inconvenience to users; this change is completely outside the control of UCD NVRL.

 

Any queries in relation to this notification should be addressed to the Clinical Team on 01-7164401.

 

 

CN-23-27